Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) Whether the extended period of limitation could be invoked on the basis of a subsequent show cause notice arising out of the same audit report and set of facts. (ii) Whether clearances of branded medicaments manufactured for others were to be included for computing the turnover limit under Notification No. 8/2003-CE.
Issue (i): Whether the extended period of limitation could be invoked on the basis of a subsequent show cause notice arising out of the same audit report and set of facts.
Analysis: The two notices were founded on the same audit material. Once the earlier notice had already put the department in possession of the relevant facts, the later notice could not rest on suppression for invoking the extended period. The dispute was also one of interpretation of the notification condition, and in such a case suppression with intent to evade duty was not made out.
Conclusion: The invocation of the extended period of limitation was not sustainable and is against the Revenue.
Issue (ii): Whether clearances of branded medicaments manufactured for others were to be included for computing the turnover limit under Notification No. 8/2003-CE.
Analysis: Goods bearing another person's brand name were specifically outside the benefit of Notification No. 8/2003-CE. Their clearance could not be counted for determining eligibility under the small scale exemption merely because such goods might be exempt under some other notification. Reading such clearances into the turnover limit would add a condition not found in the notification and would be impermissible.
Conclusion: The branded medicaments were not includible for computing the exemption threshold and this issue is in favour of the assessee.
Final Conclusion: The demand and penalty could not be sustained either on limitation or on merits, and the appeals succeeded with consequential relief.
Ratio Decidendi: A subsequent notice based on the same audit facts cannot invoke the extended period on suppression, and the turnover for a small scale exemption must be computed strictly according to the notification without importing conditions not expressed in it.